China’s New GMP Takes Effect Nov 1, 2026, as NMPA Issues Four New Inspection Guidelines October 30, 2026
NMPA Clinical Trial Guideline on Implanted BCI Hand-Movement Compensation System: Key Focus on Patient Eligibility, Clinical Endpoints, and Lifecycle Evidence October 30, 2026
Inspection Points for IVD Reagents: Centering on Control of Contamination, Traceability and Contract Manufacturing October 26, 2026
